← FDA DRUG APPROVALS

FDA ANDA · ANDA211857

VASOPRESSIN

Sponsor: AMPHASTAR PHARMS INC

APPLICATION
ANDA211857
TYPE
ANDA
ORIGINAL APPROVAL
2022-07-18
LATEST ACTION
2022-07-18
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

VASOPRESSINPrescription
VASOPRESSIN 20UNITS/ML (20UNITS/ML) · SOLUTION · INTRAVENOUS

Approval history

2022-07-18UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →